Product NDC: | 55150-123 |
Proprietary Name: | Nafcillin |
Non Proprietary Name: | Nafcillin Sodium |
Active Ingredient(s): | 2 g/8mL & nbsp; Nafcillin Sodium |
Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS |
Dosage Form(s): | INJECTION, POWDER, FOR SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 55150-123 |
Labeler Name: | AuroMedics Pharma LLC |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA091613 |
Marketing Category: | ANDA |
Start Marketing Date: | 20121226 |
Package NDC: | 55150-123-15 |
Package Description: | 10 VIAL in 1 BOX (55150-123-15) > 8 mL in 1 VIAL |
NDC Code | 55150-123-15 |
Proprietary Name | Nafcillin |
Package Description | 10 VIAL in 1 BOX (55150-123-15) > 8 mL in 1 VIAL |
Product NDC | 55150-123 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Nafcillin Sodium |
Dosage Form Name | INJECTION, POWDER, FOR SOLUTION |
Route Name | INTRAMUSCULAR; INTRAVENOUS |
Start Marketing Date | 20121226 |
Marketing Category Name | ANDA |
Labeler Name | AuroMedics Pharma LLC |
Substance Name | NAFCILLIN SODIUM |
Strength Number | 2 |
Strength Unit | g/8mL |
Pharmaceutical Classes | Penicillin-class Antibacterial [EPC],Penicillins [Chemical/Ingredient] |